The high expression rate of PD‐L1 in NECC indicates the great potential of PD‐L1i, at that the some neuroendocrine carcinomas were researched to admit sensitivity and effectiveness for PD‐L1 inhibitors.10, 11. Here, CD274 is linked to neuroendocrine carcinoma.